{"organizations": [], "uuid": "641eb628860354dada8e4bac5c2fd4778dcde5c0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180326.html", "section_title": "Archive News &amp; Video for Monday, 26 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-cambridge-cognition-announces-awar/brief-cambridge-cognition-announces-award-of-major-new-pharmaceutical-clinical-trial-contract-idUSASO0002IL", "country": "US", "domain_rank": 408, "title": "BRIEF-Cambridge Cognition Announces Award Of Major New Pharmaceutical Clinical Trial Contract", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.679, "site_type": "news", "published": "2018-03-26T14:40:00.000+03:00", "replies_count": 0, "uuid": "641eb628860354dada8e4bac5c2fd4778dcde5c0"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-cambridge-cognition-announces-awar/brief-cambridge-cognition-announces-award-of-major-new-pharmaceutical-clinical-trial-contract-idUSASO0002IL", "ord_in_thread": 0, "title": "BRIEF-Cambridge Cognition Announces Award Of Major New Pharmaceutical Clinical Trial Contract", "locations": [], "entities": {"persons": [], "locations": [{"name": "uk", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "cambridge cognition holdings plc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 26 (Reuters) - Cambridge Cognition Holdings Plc :\n* MAJOR CONTRACT WIN AND FUNDING AWARD * AWARD OF A MAJOR NEW PHARMACEUTICAL CLINICAL TRIAL CONTRACT AND A DIGITAL HEALTH CATALYST GRANT FROM INNOVATE UK\n* NEW CLINICAL TRIAL CONTRACT IS LARGER OF 2 CONTRACTS, COLLECTIVELY TOTALLING Â£2.3M, ORIGINALLY EXPECTED IN LAST QUARTER OF 2017\n* CONTRACT FOR MULTI-NATIONAL PHASE IV CLINICAL STUDY WITH PHARMACEUTICAL CO, WHICH WILL HAVE MATERIAL IMPACT ON 2018, 2019 REVENUES Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-26T14:40:00.000+03:00", "crawled": "2018-03-27T11:43:17.017+03:00", "highlightTitle": ""}